Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Eskiyurt, Nurten; Irdesel, Jale; Sepici, Vesile; Ugurlu, Hatice; KİRAZLI, YEŞİM; ARDIÇ, FÜSUN; BÜTÜN, BÜLENT; Akyuz, Gulseren; Cerrahoglu, Lale; ŞENDUR, ÖMER; Yalcin, Peyman; Oncel, Sema; Saridogan, Merih; SARPEL, TUNAY; Tosun, Mehmet; Kutsal, Yesim; Senel, Kazim; Gursoy, Savas; Canturk, Ferhan; DEMİR, HÜSEYİN; Ozdener, Fatih; Oncel, Hakan

doi:10.4274/tod.29491

Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study

Copy For Citation

Eskiyurt N., Irdesel J., Sepici V., Ugurlu H., KİRAZLI Y., ARDIÇ F., ...More

TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS, vol.18, no.1, pp.1-7, 2012 (ESCI)

Publication Type: Article / Article
Volume: 18 Issue: 1
Publication Date: 2012
Doi Number: 10.4274/tod.29491
Journal Name: TURK OSTEOPOROZ DERGISI-TURKISH JOURNAL OF OSTEOPOROSIS
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
Page Numbers: pp.1-7
Hacettepe University Affiliated: Yes

Abstract

Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or weekly alendronate or risendronate.